Nuclear medicine imaging of lung cancer

Radiologic Clinics of North America

Volumn 38, Issue 3, 2000, Pages 511-524

  Goldsmith, Stanley J ^a,b   Kostakoglu, Lale ^b  

^a Department of Population Medicine and Diagnostic Sciences   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M;

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; LUNG CANCER; LUNG NODULE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034040399     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(05)70181-0     Document Type: Article

References (36)

1. J.E. Blum H. Handmaker N.A. Rinne The utility of a somatostatin-type receptor binding peptide in the evaluation of solitary pulmonary nodules Chest 115 1999 224 232
2. T. Bury A. Dowlati P. Paulus Staging of non–small cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography Eur J Nucl Med 23 1996 204 206
3. R.E. Coleman C.M. Laymon T.G. Turkington FDG Imaging of lung nodules: A phantom study comparing SPECT, camera-based PET, and dedicated PET Radiology 210 1999 823 828
4. N.A. Dewan N.C. Gupta L.S. Redepenning Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management Chest 104 1993 997 1002
5. N.A. Dewan S.D. Reeb N.C. Gupta PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis Chest 108 1995 441 446
6. B.A. Dwamena S.S. Sonnad J.O. Angobaldo Metastases from non–small cell lung cancer: Mediastinal staging in the 1990s—Meta-analytic comparison of PET and CT Radiology 213 1999 530 536
7. S.S. Gambhir J.E. Shephard H. Handmaker Analysis of the cost effectiveness of a somatostatin analog-Tc99m-depreotide (Neotect) in the scintigraphic evaluation of solitary pulmonary nodules (SPN) J Nucl Med 40 1999 57P
8. A. Gdeedo P. Van Schil B. Corthouts Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging Eur Respir J 10 1997 1547 1551
9. N.C. Gupta J. Maloof E. Gunel Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET J Nucl Med 37 1996 943 948
10. J.W. Gurney Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory Radiology 186 1993 405 413
11. J.W. Gurney D.M. Lyddon J.A. McKay Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application Radiology 186 1993 415 422
12. M. Hebert V. Lowe J. Hoffman Positron emission tomography in the pretreatment evaluation and follow-up of non–small cell lung cancer patients treated with radiotherapy Am J Clin Oncol 19 1996 416 421
13. K. Higashi Y. Ueda H. Seki Fluorine-18-FDG PET imaging is negative in bronchiolo-alveolar lung carcinoma J Nucl Med 39 1998 1016 1020
14. T. Inoue E.E. Kim R. Komaki Detecting recurrent or residual lung cancer with FDG-PET J Nucl Med 36 1995 788 793
15. S.B. Knight D. Delbeke J.R. Stewart Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy Chest 109 1996 982 988
16. K. Kubota Differential diagnosis of lung tumor with positron emission tomography: A prospective study J Nucl Med 31 1990 1927 1932
17. P. Lewis S. Griffin P. Marsden Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer Lancet 344 1994 1265 1266
18. V.J. Lowe F.G. Duhaylongsod E.F. Patz Pulmonary abnormalities and PET data analysis: A retrospective study Radiology 202 1997 435 439
19. V.J. Lowe J.W. Fletcher L. Gobar Prospective investigation of positron emission tomography in lung nodules J Clin Oncol 16 1998 1075 1084
20. V.J. Lowe E.F. Patz L. Harris FDG-PET evaluation of pleural abnormalities [abstract] J Nucl Med 35 1994 229P
21. O.S. Nettelbladt A.E. Sundin S.O. Valind Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum J Nucl Med 39 1998 640 647
22. K.B. Nolop C.G. Rhodes L.H. Brudin Glucose utilization in vivo by human pulmonary neoplasms Cancer 60 1987 2682 2689
23. E. Patz V.J. Lowe J.M. Hoffman Detection of persistent or recurrent bronchogenic carcinoma using 18F-2-deoxy-D-glucose and positron emission tomography (PET) imaging Radiology 191 1994 379 382
24. E.J. Patz V.J. Lowe J.M. Hoffman Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
25. M. Salathe M. Soler C.T. Bolliger Transbronchial needle aspiration in routine fiberoptic bronchoscopy Respiration 59 1992 5 8
26. D.A. Schenk J.H. Bower C.L. Bryan Transbronchial needle aspiration staging of bronchogenic carcinoma Am Rev Respir Dis 134 1986 146 148
27. J.E. Shepherd M.E. Phelps J. Czernin Cost effectiveness analysis for the role of FDG-PET in lung carcinoma J Nucl Med 40 1999 56P
28. H.C. Steinert M. Hauser F. Alleman Non–small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling Radiology 202 1997 441 446
29. J.K. Stoller M. Ahmad T.W. Rice Solitary pulmonary nodules Clev Clin J Med 55 1988 68 71
30. P.E. Valk T.R. Pounds D.M. Hopkins Staging non–small cell lung cancer by whole-body positron-emission tomographic imaging Ann Thorac Surg 60 1995 15733 11582
31. J.F. Vansteenkiste K.A. Mortelmans FDG-PET in the locoregional lymph node staging of non–small cell lung cancer. A comprehensive review of the Leuven Lung Cancer Group Experience Clin Pos Imaging; 2 1999 223 231
32. 99mTc-P829 Cancer Res 58 1998 1850 1859
33. R.L. Wahl Targeting glucose transporters for tumor imaging: “Sweet” idea, “sour” result [editorial] J Nucl Med 37 1996 1038 1041
34. R.L. Wahl L.E. Quint R.L. Greenough Staging of mediastinal non–small cell lung cancer with FDG PET CT and fusion images: Preliminary perspective evaluation Radiology 191 1994 371 377
35. W. Weber H. Bulow W. Romer FDG-PET in solitary pulmonary nodules: A German cost-effectiveness analysis J Nucl Med 38 1997 245P
36. W.R. Webb C. Gatsonis E.A. Zerhouni CT and MR imaging in staging non–small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group Radiology 178 1991 705 713